Research & Development

日韩在线av直接观看99久久免费热在线精品久久re6热在线精品视频获新乳业战略入股7亿元 现代牧业续涨超5%


  平叟揮揮手就上了馬車,很快就驅車上了古道,車馬轔轔,被護衛家僕簇擁著去了陽陵邑那座繁華的地方。   紅袖站在雲瑯面前的時候,如同一只受傷的小獸,一個勁的往相對熟悉的丑庸懷里鑽。日韩在线av直接观看   至少在規模上比雲瑯當大掌櫃的時候大了兩倍不止,看樣子這里的生意很好。99久久免费热在线精品   一丁點咸魚,老虎一口就吃沒了……   雲瑯用元朔犁,耬車,水車,水磨來換取皇家的三十頃地已經成了長安市上的最大笑話。久久re6热在线精品视频   小蟲翻了一個大大的白眼就軟軟的倒在地上。

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo